Search Results

Phase I study of AR-42 and decitabine in acute myeloid leukemia

Authors:Rebecca Klisovic, Emory UniversitySophia G Liva, Ohio State UniversityChristopher C Coss, Ohio State UniversityJiang Wang, US Food and Drug AdministrationWilliam Blum, Emory UniversityBhavana Bhatnagar, Ohio State UniversityKatherine Walsh, Ohio State UniversitySusan Geyer, Mayo Clinic, RochesterQiuhong Zhao, Ohio State UniversityRamiro Garzon, Ohio State UniversityGuido Marcucci, City of Hope, DuarteMitch A Phelps, Ohio State UniversityAllison Walker, Emory University

Date:2020

Publisher:TAYLOR & FRANCIS LTD

Publication Version:Author Accepted Manuscript (After Peer Review)

License:Creative Commons Attribution-NonCommercial 4.0 International

Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Authors:Hongjing Zang, Emory UniversityGuoqing Qian, Emory UniversityDan Zong, Emory UniversitySongqing Fan, Central South UniversityTaofeek Owonikoko, Emory UniversitySuresh Ramalingam, Emory UniversityShi-Yong Sun, Emory University

Date:2020

Publisher:Wiley

Publication Version:Author Accepted Manuscript (After Peer Review)

Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor

Authors:Saumya S. Gurbani, Emory UniversityBrent Weinberg, Emory UniversityEric Salgado, Emory UniversityAlfredo Voloschin, Emory UniversityJose Velazquez Vega, Emory UniversityJeffrey Olson, Emory UniversityHui-Kuo Shu, Emory UniversityHyunsuk Shim, Emory University

Date:2020

Publisher:Oxford University Press

Publication Version:Final Published Version

License:Creative Commons Attribution-NonCommercial 4.0 International

HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL

Authors:Xuehai Bian, Emory UniversityZhongxing Liang, Emory UniversityAmber Feng, Emory UniversityEric Salgado, Emory UniversityHyunsuk Shim, Emory University

Date:2018

Publisher:Elsevier: 12 months

Publication Version:Author Accepted Manuscript (After Peer Review)

License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

Search

Search Constraints

Phase I study of AR-42 and decitabine in acute myeloid leukemia

Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor

HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL

Limit your search

Authors

Date

Journal or Parent Publication Title

Type

Publication Version

Keyword